EpiGentek Investor

Biotechnology investments.


Invests into

Technology: Immunotherapy
Industry: PharmTech
Founded Date: 2005
Investor Type: N/A
Employee Number: 11-50
Investment Stage: N/A
Total Funding: N/A
Headquarters: New York, United States
Estimated Revenue: $1M to $10M